Latest Pulmonology Stories
Conference Call Today, March 13, 2014 at 10:00 a.m. ET WARRINGTON, Pa., March 13, 2014 /PRNewswire/ -- Discovery Laboratories, Inc.
-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides
National Campaign Seeks to Educate People with Asthma on the Importance of 'Knowing Their Count' LANDOVER, Md., March 5, 2014 /PRNewswire/ -- The Asthma and Allergy Foundation of America
The Use of Respiratory Therapists as case managers or physician extenders will improve health outcomes, reduce costs and help organizations to demonstrate meaningful use for patients diagnosed
Bronchial Thermoplasty is the first non-drug, FDA approved therapy for severe asthma CHICAGO, Feb.
VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S.
This unique program will bring together key stakeholders who have a shared goal of improving the treatment and management of patient’s with Chronic Obstructive Pulmonary Disease (COPD).
Study Aims To Evaluate Improvement in Lung Function after Treatment with NOxCureCF REHOVOT, Israel, February 10, 2014 /PRNewswire/ -- Advanced Inhalation Therapies
Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...
- Emitting flashes of light; glittering.